Using Virtual Reality (VR) Models for Robotic Prostatectomy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Porter, MD
Swedish Medical Center
Principal Investigator - Ketan Badani, MD
Mount Sinai Health System
Principal Investigator - Raymond Pak, MD
Mayo Clinic
Principal Investigator - Robert Reiter, MD
UCLA Urology
Principal Investigator - Thomas Ahlering, MD
UC Irvine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Urology
Los Angeles, California, United States
- Uc Irvine
Orange, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Mount Sinai Health System
New York, New York, United States
- Swedish Medical Center
Seattle, Washington, United States
- Swedish Urology Group
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2019
- Primary completion
- 30 Sept 2023
- Completion
- 30 Sept 2023
- Last update posted
- 4 Jun 2024
- Registered enrollment
- 92
- Registry id
- NCT03943368
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.